Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-23-048387

Chief Financial Officer gave up 6,310 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. Chief Financial Officer 2023-09-01 Shares withheld for taxes −6,310 $2.67 $16,848 146,481 D
Loading xslF345X05/doc4.xml…